EOLSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Evolus, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$7.36+0.26 (+3.66%)

Close on Oct 19, 2026

Market cap: $485.24M
P/E (TTM): –
Dividend yield: –

Evolus, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31
Depreciation & Amortization	1.53	2.35	2.25	1.14	0.93	1.56	1.37	0.32	0.66	1.41	1.37	1.31	1.25	1.20	1.03	0.92	0.85	0.92	0.92	0.92	1.75	2.03	1.88	1.74	1.66	1.75	1.47	1.20	0.98	0.48	0.00	0.00	0.00	0	0	0	0.11	0.11
Stock-Based Compensation	5.62	5.12	5.15	5.14	4.49	5.93	6.17	5.22	5.78	5.08	4.40	4.60	4.17	3.29	2.41	2.48	2.98	2.96	2.65	2.48	2.86	1.59	2.63	2.95	2.37	2.63	2.54	2.53	2.46	2.00	1.86	1.48	2.62	1.01	0.11	0.23	0.10	0.14
Deferred Income Taxes	-0.58	-0.01	0.03	-0.02	0.02	-0.01	-0.02	0	0.00	0.01	0.01	0	0	0	0.00	0.00	0.01	-0.02	0.02	0	0	0	-0.15	-0.01	-0.07	0.26	-0.16	-0.15	-0.23	-15	0.02	0.02	0.01	0.01	-6.31	0.02	0.02	0.02
Other Non-Cash Items	–	–	–	–	–	-0.15	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Change in Accounts Receivable	-11	2.15	-4.79	-4.94	-0.96	-0.82	-3.83	-2.38	-9.49	-3.90	-0.15	-2.48	-5.61	-1.28	-1.76	-0.52	-4.50	-2.61	-1.46	-1.61	-3.75	1.25	2.09	-2.58	1.76	-2.35	-3.84	-5.80	-1.41	0	0	0	–	–	–	–	–	–
Change in Inventory	-1.33	6.38	4.66	-11	-8.34	4.05	0.98	-1.48	-1.56	5.31	4.85	4.96	0.85	-6.46	4.60	-2.66	-7.05	-5.57	4.18	-7.18	-3.13	3.15	3.01	1.27	2.20	-1.93	1.74	5.30	-8.94	-2.58	0	0	0	0	–	–	–	–
Change in Accounts Payable	2.63	-7.61	2.05	4.11	-0.78	4.72	-2.89	3.53	-1.16	0.91	-5.81	1.36	0.28	3.14	-1.37	-2.06	2.92	1.47	1.53	-0.76	0.26	-1.81	5.17	3.73	-6.91	0.33	-0.55	-13	13	0.31	0.90	-2.03	2.20	0.21	0.12	-0.21	-0.36	-1.99
Operating Cash Flow	-3.59	-9.95	13	-15	-25	-16	4.81	-5.72	-6.47	-11	0.81	-0.92	-13	-21	-8.77	-17	-21	-38	-9.04	-32	16	-8.34	-2.27	-14	-14	-28	-16	-25	-33	-19	-12	-5.80	-5.66	-2.20	-1.00	-3.43	-3.21	-5.58
Capital Expenditures	-0.05	-0.42	-1.48	-0.96	-0.69	-0.32	-0.44	-0.31	-0.47	-0.26	-0.21	-0.03	-0.01	-0.23	-0.87	-0.51	-0.23	-0.01	-0.39	0	0	0	-0.02	-0.12	-0.11	-0.57	0.00	0	-0.35	0	0	0	–	–	0	0	–	–
Purchase of Investments	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	-25	-50	-15	-4.97	-15	-79	0	0	0	0	–	–	–	–
Investing Cash Flow	-0.50	-1.69	-2.17	-2.16	-2.27	-1.86	-1.36	-1.41	-1.25	-0.80	-0.36	-0.54	-0.22	-0.51	-1.39	-0.90	-0.39	-0.26	-0.39	0.02	-0.39	4.79	20	29	9.38	-46	14	34	8.23	-80	0	0	-0.01	0	0	0	–	–
Stock Issued	–	–	0	0	0	0	0	0	4.21	47	–	–	–	–	–	–	–	–	–	–	0.64	0.01	0	0	0	0	72	0.31	0.80	0	11	0	0	56	0	–	–	–
Debt Issued	–	10	–	–	–	0	0	0	–	–	25	0	–	–	0	0	–	–	–	–	–	–	–	–	0	0	0	0	0	74	0	0	0	0	–	–	–	–
Debt Repaid	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	-76	0.00	0	0	-0.52	-0.34	-0.71	0	0	0	–	–	–	–	–	–	–
Taxes Paid on Share-Based Awards	–	0	–	–	–	-0.01	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	–	-0.06	0	0	-0.24	0	0	0	–	–
Financing Cash Flow	-0.37	7.62	0.08	-1.77	21	-1.63	-1.31	-1.42	4.48	46	24	-1.42	24	-1.28	-1.52	-0.76	-0.85	-1.02	48	8.16	94	-77	0	40	-0.32	-1.11	73	-0.46	0.85	60	0	67	-0.31	52	1.00	3.43	3.21	5.39
Foreign Exchange Rate Adjustments	-0.17	-0.01	-0.44	0.38	0.24	0.07	-0.22	-0.09	-0.04	-0.13	0.18	-0.14	-0.05	-0.08	0.03	-0.20	-0.06	-0.10	0	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Change in Cash	-4.62	-4.03	10	-18	-6.16	-19	1.92	-8.64	-3.29	34	24	-3.02	10	-22	-12	-19	-22	-40	38	-24	110	-80	17	55	-4.88	-75	–	8.83	-24	-39	-12	62	-5.99	50	0	0	–	–
Free Cash Flow	-3.64	-10	11	-16	-25	-16	4.37	-6.04	-6.94	-11	0.60	-0.95	-13	-21	-9.64	-18	-21	-38	-9.44	-32	16	-8.34	-2.28	-14	-14	-29	-16	-25	-34	-19	-12	-5.80	–	–	-1.00	-3.43	–	–
Income Taxes Paid	0.20	0.03	0.74	0.16	0.27	0.05	0.04	0.03	0.14	0.03	0.02	0.04	0.03	0.03	0.01	0.02	0.05	0	0.01	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Interest Paid	0.30	3.25	3.44	3.56	3.73	4.06	4.23	4.47	4.41	4.42	3.80	3.52	5.39	0	2.35	2.07	1.80	1.78	0.06	0	0	0.08	1.80	1.82	1.82	1.80	1.80	1.82	1.21	0.34	0	0	0	0	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 66.7%
Operating margin: -5.9%
Net margin: -10.8%
Return on equity, FY2025: 587.4%

Financial strength

Current ratio: 1.70
Debt to equity: -5.07
Debt to assets: 63.2%
Cash to current liabilities: 45.8%

Valuation

P/E ratio: –
Price to sales: 1.53
Price to book: –
Dividend yield: –